Atlantic Bridge

Atlantic Bridge Services Limited is a private equity and venture capital firm based in Dublin, Ireland, with additional offices in London, Palo Alto, Munich, and Paris. Founded in 2004, the firm specializes in growth-stage investments in technology and life sciences sectors, focusing on areas such as artificial intelligence, machine learning, cybersecurity, cloud computing, and advanced manufacturing. Atlantic Bridge targets companies with global market potential, primarily in the United States, Ireland, and Europe. Its investment strategy typically involves deploying between €5 million and €20 million in businesses with revenues ranging from €15 million to €50 million. The firm seeks minority stakes and aims to secure board representation in its portfolio companies, often looking to exit through initial public offerings or trade sales within five to eight years. Atlantic Bridge combines a team of experienced technology entrepreneurs and finance professionals to implement a unique transatlantic investment model that facilitates the scaling of companies in international markets.

Dougal Adamson

Investment Associate

Thomas Alt Ph.D

Venture Partner

Alpesh Amin

Partner

Gianmarco del Bono

Associate

Elaine Coughlan

Co-Founder & Managing Partner

Alison Crawford

Senior Investment Associate

Kevin Dillon

Co-Founder & Managing Partner

Conor Doyle

Investor

Eimear Gleeson

Senior Associate

Eimear Glesson

Investment Associate

Jingwan (Viki) Huang

Associate

Paul Harvey

General Partner

Cillian Hilliard

Investment Associate

Mark Horgan

General Partner & Chief Financial Officer

Christopher Horn Ph.D

Senior Advisor

Kathy Kelly

Senior Investment Associate

David Lam

General Partner

Dominik Leisi

Senior Associate

Brian Long

Co-Founder & Managing Partner

Gerry Maguire

General Partner

Helen McBreen

Partner

Peter McManamon

Chairman

Georgina Murphy

Investment Associate

Paul Murray

Partner

Senan O'Mahony

Associate

Conor O’Sullivan

Investment Director

Larry Quinn

Venture Partner

Ahmad Raza

Associate

Weili Wang

Investment Associate

Mélissa Yvonnou

Investment Director

Past deals in Ireland

Ubotica

Seed Round in 2022
Developer of semi-autonomous satellite systems designed to deliver real-time insights from space-based systems directly to users. The company provides technical expertise in the areas of computer vision and machine learning in embedded systems for several different market segments including space, IoT, Industry, and biomedical, enabling clients to get maximum output from satellites.

PlasmaBound

Venture Round in 2022
PlasmaBound Ltd. specializes in pre-treatment services for fibre-reinforced composites, aiming to reduce the weight of heavy assemblies and enhance product quality. The company utilizes a patent-pending technology called Controlled Plasma Ablation (CPA), which modifies atmospheric plasma to create a surface on composite materials that improves adhesive bonding without activating the polymeric surface. This innovative approach facilitates the integration of lightweight materials, such as carbon and glass fibre reinforced composites, into multi-material structural assemblies, offering stronger adhesive joints than the composites themselves. PlasmaBound serves various industries including aerospace, transportation, marine, renewable energy, and consumer electronics. Founded in 2017, the company is headquartered in Dublin, Ireland.

Trustap

Seed Round in 2022
Trustap Ltd is a transaction platform established in 2016 and based in Carrigaline, Ireland. The platform functions as a personal escrow service, designed to safeguard buyers and sellers during online or in-person transactions with unfamiliar parties. By acting as a third party, Trustap ensures that transactions are completed successfully without the risk of scams. The platform incorporates specific models tailored to various transaction scenarios, such as face-to-face exchanges and online shipments through integrated couriers. Trustap's secure payment technology holds the buyer's funds in a safe account until all agreed-upon transaction milestones are achieved and a designated complaints period has elapsed, promoting a safer and more reliable digital payment experience.

CroíValve

Series A in 2022
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation

Tympany Medical

Seed Round in 2021
Tympany Medical focuses on advancing minimally invasive ear surgeries through innovative technology. The company has developed a specialized ear surgery device that provides a sterile endoscopic solution for complex procedures in otolaryngology. This device addresses key challenges related to the usability and flexibility of traditional endoscopes, allowing surgeons to benefit from enhanced visualization while preserving their two-handed operating techniques. By reducing the necessity for mastoidectomies, Tympany Medical aims to improve surgical outcomes and streamline the process of ear surgeries, ultimately enhancing patient care in the field of ENT.

LUMA Vision

Series A in 2021
OneProjects Design and Innovation Ltd. develops healthcare technologies for the treatment of cardiac arrhythmias. It offers VERAFEYE, a connected platform technology to revolutionize the treatment of AFib and cardiac arrhythmias. The company was incorporated in 2017 and is based in Dublin, Ireland.

Ambisense

Venture Round in 2021
Since 2014 Ambisense has been driving innovation within the environmental space. Our technology platform optimizes the delivery of environmental risk assessment on some of the world’s largest infrastructure projects across industrial, O&G and waste verticals. Ambilytics encompasses both IoT and ML solutions, combining information from remotely deployed field devices with contextual data sources such as weather, satellite, geophysical and operational data to build machine learning models. These models identify the relationships, patterns, and drivers hidden within the data and allow our customers to forecast and predict the behaviour of targeted environmental pollutants.
Kastus Antimicrobial Technologies are a small team of experienced professionals with expertise in fields ranging from nanotechnology, physics, product development, research & development, coating and production. They at Kastus fund, develop, commercialise and license a range of unique patent pending anti-microbial surface treatments offering Log 4+ kill rates against bacteria, fungi and antibiotic-resistant superbugs including MRSA and E. coli. Their proprietary antimicrobial coating technology, Log4+ was developed in response to government, industry & healthcare requests to help reduce the spread of infections caused by bacteria and fungi surviving on surfaces in the indoor environment. They at Kastus license their unique visible light activated nanotechnology for all glass and ceramic substrates. Having completed 5+ years of research, development & testing at external ISO accredited laboratories their patent pending technology allows a selection of clients to offer enhanced and unique customer benefits and selling points. When utilised in touch surfaces, cleanroom and medical environments the financial and human benefits are significant. Their technology is factory applied using patent pending processes creating environmentally safe (non-leaching), long lasting and economical products providing a second layer of defence against the growing global threats posed by antibiotic resistant bacteria. Log4+allow users to achieve a 99.99% reduction in both gram positive & gram negative bacteria (MRSA, E-coli, and Pseudomonas) under indoor light conditions at normal room temperatures and humidity levels without using any harmful silver or volatile organic compounds (VOCs). Their technology is independently certified, is visible light activated not requiring UV, is permanent, non-leeching, contains no silver, is economic & commercially viable and non-toxic. Log4+ is applicable to all glass and ceramic types, it is scratch resistant and visually clear and importantly it does not alter the host glass or ceramic in terms of functionality or appearance. Log4+ can be in-line applied resulting in production efficiencies and cost savings for their clients creating significant revenue and market share potential.

Manna Drone Delivery

Series A in 2021
Manna provides drone delivery as a service stack to restaurant chains, dark kitchens, and online food delivery platforms. Using custom-developed aerospace-grade drones, they deliver directly from restaurants and centralized kitchens to consumer's homes. It flies at an altitude of 80 meters and a speed of over 80kph, delivering within a 2km radius in less than 3 minutes.​ The company was founded in 2018 and is headquartered in Dublin, Ireland.

TerminusDB

Seed Round in 2021
TerminusDB is an open-source full-featured in-memory graph database management system with a rich query language, WOQL. TerminusDB allows for the whole suite of revision control features: branch, merge, squash, rollback, blame, and time-travel. It is about taking data seriously, structuring data to meet business needs, and reducing the code required to display, distribute and manipulate data and support great decision making. TerminusDB was previously known as DataChemist, was founded in Dublin, Ireland.

Atlantic Therapeutics Limited

Venture Round in 2021
Atlantic Therapeutics is a medical technology company that develops pelvic floor muscle strengthening and nerve stimulation products. The company's devices focus on the treatment of all types of incontinence, sexual health dysfunctions, and other associated disorders by strengthening muscles and modulating nerves of the pelvic floor, enabling bladder patients to treat their conditions associated with pelvic floor weakness. Its products are backed by strong clinical evidence and subjected to controlled trials. It was established in Galway, Galway in 2013.

Neurent Medical

Series B in 2021
Neurent Medical Limited develops medical device for treating rhinitis. The company offers a single-use device for ENT surgeons to treat both allergic and non-allergic rhinitis. The company was founded in 2015 and is headquartered in Galway, Ireland.

Parvalis Therapeutics

Venture Round in 2021
Parvalis Therapeutics develops novel autoimmune therapies for inflammatory diseases and cancer. Founded in 2020, the company is based in Dublin, Ireland.

PlasmaBound

Seed Round in 2020
PlasmaBound Ltd. specializes in pre-treatment services for fibre-reinforced composites, aiming to reduce the weight of heavy assemblies and enhance product quality. The company utilizes a patent-pending technology called Controlled Plasma Ablation (CPA), which modifies atmospheric plasma to create a surface on composite materials that improves adhesive bonding without activating the polymeric surface. This innovative approach facilitates the integration of lightweight materials, such as carbon and glass fibre reinforced composites, into multi-material structural assemblies, offering stronger adhesive joints than the composites themselves. PlasmaBound serves various industries including aerospace, transportation, marine, renewable energy, and consumer electronics. Founded in 2017, the company is headquartered in Dublin, Ireland.

LUMA Vision

Series A in 2020
OneProjects Design and Innovation Ltd. develops healthcare technologies for the treatment of cardiac arrhythmias. It offers VERAFEYE, a connected platform technology to revolutionize the treatment of AFib and cardiac arrhythmias. The company was incorporated in 2017 and is based in Dublin, Ireland.

Output Sports

Seed Round in 2020
Output Sports operates as a sports tech start-up. We are revolutionizing the way athletic staff optimize sports performance. Using advanced signal processing and machine learning techniques we have developed an end-to-end solution that can test multiple components of athletic performance and track training programmes with a single wearable sensor.

AYLIEN

Series A in 2019
AYLIEN is an artificial intelligence startup based in Wilmington, Delaware, specializing in technologies that enhance machine understanding of human languages. The company offers a variety of tools and APIs, including text analysis and news APIs, which enable users to process and interpret large volumes of human-generated content effectively. Its key products include Talk.ee, a tool for collecting and categorizing information, and the AYLIEN App Engine, which provides a platform for developing micro applications that transform unstructured data into structured formats. Additionally, AYLIEN offers oTaste, a tool designed for digitizing human tastes. The company serves a diverse clientele, including developers, data scientists, marketers, and academics, providing solutions in information retrieval, machine learning, natural language processing, and image recognition.

Manna Drone Delivery

Seed Round in 2019
Manna provides drone delivery as a service stack to restaurant chains, dark kitchens, and online food delivery platforms. Using custom-developed aerospace-grade drones, they deliver directly from restaurants and centralized kitchens to consumer's homes. It flies at an altitude of 80 meters and a speed of over 80kph, delivering within a 2km radius in less than 3 minutes.​ The company was founded in 2018 and is headquartered in Dublin, Ireland.

Siren

Series A in 2019
Siren is a software company that provides an Investigative Intelligence platform to complex organizations and derive business value. The platform provides a unique combination of search, business intelligence, big data, link analysis and knowledge representation which advances the way organizations address some of the world’s most important data-driven problems. Siren makes it easier to use the data you collect to answer questions and make links, find patterns and relationships. It also uniquely enables this in real-time at a scale that companies and government organizations require. it easy to leverages and deploy data directly on backends such as Elasticsearch, relational databases, virtual data warehouses, and graph databases. Siren was awarded the Technology Innovation of the Year and Enterprise of the Year (SME) at the Information Technology Association of Galway (ITAG) Excellence Awards and also was named the Irish Startup of the Year at Ireland’s National Tech Excellence Awards. Siren was founded in 2014 and is based in Galyway, Ireland.

Atrian Medical

Seed Round in 2019
AtriAN is commercializing technology created at Mayo Clinic in the US. AtriAN is an Irish Medical Device company based in Galway--A powerful and prolific hub for medical devices.AtriAN uses a gentle energy, micro Pulsed Electric Fields (mPEF) to only ablate hyperactivity. The other tissues such as the myocardium are spared.

iQuate

Venture Round in 2019
iQuate offers its users with enterprise software analysis and discovery services. The regional offices of the company are located across the U.S. and France. It provides global enterprise customers with visibility of their IT estates, focusing on the deployment positions of the software vendors. It is a foundation of optimization for business decisions and it is verified by Oracle LMS. The platform enables its users to see through data center complexity, helping them manage and optimize their IT assets to drive cost savings and efficiencies. It offers its users with IT transformation and cloud infrastructure management, IT operations and service management, and software license compliance and optimization services. The company is bestowed with numerous awards such as multiple Microsoft global SAM awards and it is a recipient of a Gartner 2013 Cool Vendor Award. iQuate is an Ireland-based company that was founded in 2002 by Jason Keogh.

CroíValve

Seed Round in 2019
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation

Ambisense

Venture Round in 2019
Since 2014 Ambisense has been driving innovation within the environmental space. Our technology platform optimizes the delivery of environmental risk assessment on some of the world’s largest infrastructure projects across industrial, O&G and waste verticals. Ambilytics encompasses both IoT and ML solutions, combining information from remotely deployed field devices with contextual data sources such as weather, satellite, geophysical and operational data to build machine learning models. These models identify the relationships, patterns, and drivers hidden within the data and allow our customers to forecast and predict the behaviour of targeted environmental pollutants.

Manna Drone Delivery

Seed Round in 2019
Manna provides drone delivery as a service stack to restaurant chains, dark kitchens, and online food delivery platforms. Using custom-developed aerospace-grade drones, they deliver directly from restaurants and centralized kitchens to consumer's homes. It flies at an altitude of 80 meters and a speed of over 80kph, delivering within a 2km radius in less than 3 minutes.​ The company was founded in 2018 and is headquartered in Dublin, Ireland.

Ambisense

Venture Round in 2019
Since 2014 Ambisense has been driving innovation within the environmental space. Our technology platform optimizes the delivery of environmental risk assessment on some of the world’s largest infrastructure projects across industrial, O&G and waste verticals. Ambilytics encompasses both IoT and ML solutions, combining information from remotely deployed field devices with contextual data sources such as weather, satellite, geophysical and operational data to build machine learning models. These models identify the relationships, patterns, and drivers hidden within the data and allow our customers to forecast and predict the behaviour of targeted environmental pollutants.

CroíValve

Seed Round in 2019
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
Atlantic Therapeutics is a medical technology company that develops pelvic floor muscle strengthening and nerve stimulation products. The company's devices focus on the treatment of all types of incontinence, sexual health dysfunctions, and other associated disorders by strengthening muscles and modulating nerves of the pelvic floor, enabling bladder patients to treat their conditions associated with pelvic floor weakness. Its products are backed by strong clinical evidence and subjected to controlled trials. It was established in Galway, Galway in 2013.

Danalto

Seed Round in 2018
Danalto Limited develops and manufactures managed Internet of things (IoT) solutions. The company offers d - AlignSpy, an alignment device for monitoring the status and quality of open-path communications links in back- and front-haul core and feeder networks; and d - GullySpy, a flood detection and monitoring device deployed into roadside gullies, water traps, and other critical public infrastructure sites. It also provides d-IoT managed service which deploys Sense to Data business intelligence solutions to enterprises to customize long range and low power solutions depending on customer needs. The company caters to agriculture technology, facilities management, transport and logistics, electricity, water, and gas. The company was founded in 2017 and is based in Dublin, Ireland.

ApisProtect

Seed Round in 2018
ApisProtect develops an agricultural technology designed for the management and care of bees. The company uses an in-hive sensor network with long-range, cellular, and satellite-powered communication to monitor bee colonies and help beekeepers prevent losses and improve productivity. It combines the sensor data on hive conditions, health, and activity levels with its proprietary big data and machine learning techniques. ApisProtect was founded on 2017 and is headquartered in Cork, Ireland.
Kastus Antimicrobial Technologies are a small team of experienced professionals with expertise in fields ranging from nanotechnology, physics, product development, research & development, coating and production. They at Kastus fund, develop, commercialise and license a range of unique patent pending anti-microbial surface treatments offering Log 4+ kill rates against bacteria, fungi and antibiotic-resistant superbugs including MRSA and E. coli. Their proprietary antimicrobial coating technology, Log4+ was developed in response to government, industry & healthcare requests to help reduce the spread of infections caused by bacteria and fungi surviving on surfaces in the indoor environment. They at Kastus license their unique visible light activated nanotechnology for all glass and ceramic substrates. Having completed 5+ years of research, development & testing at external ISO accredited laboratories their patent pending technology allows a selection of clients to offer enhanced and unique customer benefits and selling points. When utilised in touch surfaces, cleanroom and medical environments the financial and human benefits are significant. Their technology is factory applied using patent pending processes creating environmentally safe (non-leaching), long lasting and economical products providing a second layer of defence against the growing global threats posed by antibiotic resistant bacteria. Log4+allow users to achieve a 99.99% reduction in both gram positive & gram negative bacteria (MRSA, E-coli, and Pseudomonas) under indoor light conditions at normal room temperatures and humidity levels without using any harmful silver or volatile organic compounds (VOCs). Their technology is independently certified, is visible light activated not requiring UV, is permanent, non-leeching, contains no silver, is economic & commercially viable and non-toxic. Log4+ is applicable to all glass and ceramic types, it is scratch resistant and visually clear and importantly it does not alter the host glass or ceramic in terms of functionality or appearance. Log4+ can be in-line applied resulting in production efficiencies and cost savings for their clients creating significant revenue and market share potential.

Coras

Seed Round in 2018
Coras enables customers to purchase tickets they want from the sites they already use.

TerminusDB

Seed Round in 2018
TerminusDB is an open-source full-featured in-memory graph database management system with a rich query language, WOQL. TerminusDB allows for the whole suite of revision control features: branch, merge, squash, rollback, blame, and time-travel. It is about taking data seriously, structuring data to meet business needs, and reducing the code required to display, distribute and manipulate data and support great decision making. TerminusDB was previously known as DataChemist, was founded in Dublin, Ireland.

Neurent Medical

Seed Round in 2018
Neurent Medical Limited develops medical device for treating rhinitis. The company offers a single-use device for ENT surgeons to treat both allergic and non-allergic rhinitis. The company was founded in 2015 and is headquartered in Galway, Ireland.

Volograms

Seed Round in 2018
Volograms Limited is a technology startup based in Dublin, Ireland, focused on developing a volumetric video processing solution that converts 2D videos into volumetric holograms, known as volograms. This innovative technology allows for the creation of immersive experiences in virtual and augmented reality, making it suitable for various applications such as digital productions, brand fan engagement, and professional education and training. The system is versatile, capable of working with multiple camera configurations and adaptable to both indoor and outdoor environments. Volograms aims to make reality capture more accessible by enabling content generation from videos taken with consumer-grade handheld devices. The company was incorporated in 2018 and continues to advance its offerings in the field of volumetric media.

Vectra

Series D in 2018
Vectra AI, Inc. is a cybersecurity company based in San Jose, California, specializing in artificial intelligence-based solutions for detecting and responding to cyberattacks across cloud, data center, and enterprise infrastructures. Established in 2010, Vectra focuses on safeguarding cloud and data center workloads as well as user and IoT devices. Its flagship Cognito platform enhances threat detection and investigation by leveraging AI to collect, store, and enrich network metadata, enabling real-time detection and analysis of both known and unknown threats. The company offers three key applications within the Cognito platform: Cognito Stream, which transmits security-enriched metadata to data lakes and SIEMs; Cognito Recall, a cloud-based tool for storing and investigating threats; and Cognito Detect, designed to swiftly reveal and prioritize hidden attackers. Vectra AI also has research and development centers in Dublin, Ireland; Austin, Texas; and Cambridge, Massachusetts.

DecaWave

Venture Round in 2018
DecaWave Limited is a fabless semiconductor company based in Dublin, Ireland, with additional offices in San Jose, California; Toulouse, France; and South Korea. Founded in 2004, DecaWave specializes in ultra wideband (UWB) technology, particularly for real-time location systems (RTLS) and wireless sensor networks (WSNs). The company has developed a complete, single-chip CMOS ultra wideband integrated circuit compliant with the IEEE802.15.4a standard, which supports various data rates. Its flagship product, ScenSor1, is a wireless transceiver designed for diverse applications, including manufacturing, healthcare, smart housing, security, transport, and inventory management. DecaWave collaborates with strategic partners like BlueCats and Here Technologies and serves multiple sectors, including consumer, industrial, and automotive markets. The company also provides software solutions for embedded networking and location services, positioning itself at the forefront of UWB technology innovation. As of February 2020, DecaWave operates as a subsidiary of Qorvo, Inc.

Siren

Series A in 2018
Siren is a software company that provides an Investigative Intelligence platform to complex organizations and derive business value. The platform provides a unique combination of search, business intelligence, big data, link analysis and knowledge representation which advances the way organizations address some of the world’s most important data-driven problems. Siren makes it easier to use the data you collect to answer questions and make links, find patterns and relationships. It also uniquely enables this in real-time at a scale that companies and government organizations require. it easy to leverages and deploy data directly on backends such as Elasticsearch, relational databases, virtual data warehouses, and graph databases. Siren was awarded the Technology Innovation of the Year and Enterprise of the Year (SME) at the Information Technology Association of Galway (ITAG) Excellence Awards and also was named the Irish Startup of the Year at Ireland’s National Tech Excellence Awards. Siren was founded in 2014 and is based in Galyway, Ireland.
iheed is an online medical education company that designs, develops, and delivers online accredited post-graduate education programs and degrees in partnership with medical universities. The company is built by doctors and healthcare professionals (HCPs) for doctors and healthcare professionals. iheed offers certificate, diploma, and Masters level education material to HCPs, packaged in modules. It utilizes technologies to offer the students a personalized, multi-sensory, multi-device learning experience suited to their learning style. Its programs and courses are adapted to the requirements of the healthcare system in different countries combining global best practice in medical training with local population healthcare needs. Its programs and courses are aimed at addressing the broad topics of healthcare need for frontline HCPs globally such as diabetes, women’s health, neurodegenerative diseases, cardiology, travel medicine, infection control, emergency medicine, disaster planning, research methodologies, practice management, nursing and pharmacology, and more. The iheed Online Learning Environment (OLE) is a next generation cloud-based platform for online education supports interactive case-based learning methods, provides practical real-world education for practicing clinicians, and helps them build up their clinical, professional, and communication skills in patient consultation. It offers a number of features aimed at tutors and administrators such as rubrics, Speedgrader, and Turnitin to support tutors in reviewing and grading student assignments, extensive reporting and analytics, targeted messaging, and various views that enable tutors to identify students that are not keeping up with the instruction or meeting pre-defined learning thresholds. Tutors of iheed’s Tutor Network hold weekly, bi-monthly, and per topic tutorial discussions via the web conferencing system within the iheed OLE platform to ensure students are aware of what is expected of them each week, and to discuss the key learning points in the context of the students’ day-to-day practices. iheed works in partnership with many medical universities, global health organizations, and technology companies, including University of Florida Health, Qualcomm, Hamad International Training Center, Johnson & Johnson, Health Human Resources Development Center, HP, Harvard School of Public Health, Tropical Medical Bureau, and Alliance Boots. Iheed was founded in 2010 and is based in Dublin, Ireland.

AYLIEN

Venture Round in 2017
AYLIEN is an artificial intelligence startup based in Wilmington, Delaware, specializing in technologies that enhance machine understanding of human languages. The company offers a variety of tools and APIs, including text analysis and news APIs, which enable users to process and interpret large volumes of human-generated content effectively. Its key products include Talk.ee, a tool for collecting and categorizing information, and the AYLIEN App Engine, which provides a platform for developing micro applications that transform unstructured data into structured formats. Additionally, AYLIEN offers oTaste, a tool designed for digitizing human tastes. The company serves a diverse clientele, including developers, data scientists, marketers, and academics, providing solutions in information retrieval, machine learning, natural language processing, and image recognition.

Coras

Seed Round in 2017
Coras enables customers to purchase tickets they want from the sites they already use.

Ambisense

Seed Round in 2017
Since 2014 Ambisense has been driving innovation within the environmental space. Our technology platform optimizes the delivery of environmental risk assessment on some of the world’s largest infrastructure projects across industrial, O&G and waste verticals. Ambilytics encompasses both IoT and ML solutions, combining information from remotely deployed field devices with contextual data sources such as weather, satellite, geophysical and operational data to build machine learning models. These models identify the relationships, patterns, and drivers hidden within the data and allow our customers to forecast and predict the behaviour of targeted environmental pollutants.

Siren

Seed Round in 2017
Siren is a software company that provides an Investigative Intelligence platform to complex organizations and derive business value. The platform provides a unique combination of search, business intelligence, big data, link analysis and knowledge representation which advances the way organizations address some of the world’s most important data-driven problems. Siren makes it easier to use the data you collect to answer questions and make links, find patterns and relationships. It also uniquely enables this in real-time at a scale that companies and government organizations require. it easy to leverages and deploy data directly on backends such as Elasticsearch, relational databases, virtual data warehouses, and graph databases. Siren was awarded the Technology Innovation of the Year and Enterprise of the Year (SME) at the Information Technology Association of Galway (ITAG) Excellence Awards and also was named the Irish Startup of the Year at Ireland’s National Tech Excellence Awards. Siren was founded in 2014 and is based in Galyway, Ireland.
Kastus Antimicrobial Technologies are a small team of experienced professionals with expertise in fields ranging from nanotechnology, physics, product development, research & development, coating and production. They at Kastus fund, develop, commercialise and license a range of unique patent pending anti-microbial surface treatments offering Log 4+ kill rates against bacteria, fungi and antibiotic-resistant superbugs including MRSA and E. coli. Their proprietary antimicrobial coating technology, Log4+ was developed in response to government, industry & healthcare requests to help reduce the spread of infections caused by bacteria and fungi surviving on surfaces in the indoor environment. They at Kastus license their unique visible light activated nanotechnology for all glass and ceramic substrates. Having completed 5+ years of research, development & testing at external ISO accredited laboratories their patent pending technology allows a selection of clients to offer enhanced and unique customer benefits and selling points. When utilised in touch surfaces, cleanroom and medical environments the financial and human benefits are significant. Their technology is factory applied using patent pending processes creating environmentally safe (non-leaching), long lasting and economical products providing a second layer of defence against the growing global threats posed by antibiotic resistant bacteria. Log4+allow users to achieve a 99.99% reduction in both gram positive & gram negative bacteria (MRSA, E-coli, and Pseudomonas) under indoor light conditions at normal room temperatures and humidity levels without using any harmful silver or volatile organic compounds (VOCs). Their technology is independently certified, is visible light activated not requiring UV, is permanent, non-leeching, contains no silver, is economic & commercially viable and non-toxic. Log4+ is applicable to all glass and ceramic types, it is scratch resistant and visually clear and importantly it does not alter the host glass or ceramic in terms of functionality or appearance. Log4+ can be in-line applied resulting in production efficiencies and cost savings for their clients creating significant revenue and market share potential.

Accuris Networks

Venture Round in 2016
Accuris Networks, now a subsidiary of ZephyrTel, Inc., specializes in providing roaming, carrier Wi-Fi, and interworking solutions for communication service providers. Founded in 1997 and headquartered in Dublin, Ireland, with additional offices in Boston and Kuala Lumpur, the company offers a range of products including eAAA for authentication, a policy-based Wi-Fi Server for seamless integration into service provider networks, and Wi-Fi Client for offload and roaming services. Its platforms support various mobile broadband technologies such as GSM, CDMA, LTE, and Wi-Fi, ensuring a secure and unified user experience for subscribers in both domestic and international settings. Accuris also provides cloud-based solutions for service handling, mediation, and billing for Wi-Fi data usage, as well as a carrier VoIP service for operator-managed applications. The company has established strategic partnerships to enhance its offerings in the telecom sector.

Biosensia

Venture Round in 2011
Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. Its component chip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.

Firecomms

Venture Round in 2009
Firecomms is a compound semiconductor company that develops high-speed light sources in visible range wavelengths. The company's lasers and LEDs enable low-cost, high-speed optical data transmission and data capture using visible light; creating new opportunities for optical data communications in small area networks, like those used in car networks and home networks.

Biosensia

Venture Round in 2008
Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. Its component chip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.

GloNav

Series A in 2006
GloNav develops global positioning system and satellite navigation technologies and products for the wireless handset and mobile consumer electronics device markets. It offers global positioning system radio frequency integrated circuits and single chip assisted-global positioning systems, which are used for low dropout tracking and cellular handset integration. The company was founded in 2006 and is based in Newport Beach, California. It has locations in the United States, the United Kingdom, Ireland, and Taiwan. As of January 2008, GloNav, Inc. operates as a subsidiary of NXP B.V.

Firecomms

Series A in 2006
Firecomms is a compound semiconductor company that develops high-speed light sources in visible range wavelengths. The company's lasers and LEDs enable low-cost, high-speed optical data transmission and data capture using visible light; creating new opportunities for optical data communications in small area networks, like those used in car networks and home networks.

PolarLake

Venture Round in 2005
PolarLake Limited specializes in integration technology solutions, focusing on the financial services sector and other industries such as government, telecommunications, and manufacturing. Founded in 1999 and headquartered in Dublin, Ireland, the company offers a range of products designed to facilitate data sharing and distribution. Its notable offerings include a Financial Markets Reference Data Distribution solution, which benefits both buy-side and sell-side firms, as well as fund administrators and custodians. The Integration Suite allows organizations to share data and business logic effectively, while the Integration Suite Finance Edition addresses the specific integration challenges faced by financial services organizations. Additionally, PolarLake provides applications for managing OTC derivatives, including reconciliation and trade lifecycle management, alongside a Messaging Integrator to enhance communication across platforms.